Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function

Journal of the American College of Cardiology

Volumn 43, Issue 6, 2004, Pages 1004-1009

  Chen, Michael S ^a   Marrouche, Nassir F ^a   Khaykin, Yaariv ^a   Gillinov, A Marc ^a   Wazni, Oussama ^a   Martin, David O ^a   Rossillo, Antonio ^a   Verma, Atul ^a   Cummings, Jennifer ^a   Erciyes, Demet ^a   Saad, Eduardo ^a   Bhargava, Mandeep ^a   Bash, Dianna ^a   Schweikert, Robert ^a   Burkhardt, David ^a   Williams Andrews, Michelle ^a   Perez Lugones, Alejandro ^a   Abdul Karim, Ahmad ^a   Saliba, Walid ^a   Natale, Andrea ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

AF; Atrial fibrillation; CHF; Congestive heart failure; EF; Ejection fraction; ICE; Intracardiac echocardiogram; Left ventricular ventricle; LV; New York Heart Association; NYHA; Pulmonary vein; Pulmonary vein isolation; PV; PVI; QoL; Quality of life; SF 36

Indexed keywords

ADULT; ARTICLE; BIOSAFETY; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VEIN OBSTRUCTION; QUALITY OF LIFE; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SYSTOLE; TREATMENT OUTCOME; VEIN STRIPPING;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CATHETER ABLATION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY VEINS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 12144287038     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.09.056     Document Type: Article

References (27)

1. Haissaguerre M., Jais P., Shah D.C., et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 101:2000;1409-1417.
2. Haissaguerre M., Jais P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 339:1998;659-666.
3. Marrouche N.F., Dresing T., Cole C., et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation Impact of different catheter technologies. J Am Coll Cardiol. 40:2002;464-474.
4. Natale A., Pisano E., Shewchik J., et al. First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation. 102:2000;1879-1882.
5. Oral H., Knight B.P., Tada H., et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 105:2002;1077-1081.
6. Pappone C., Rosanio S., Augello G., et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. J Am Coll Cardiol. 42:2003;185-197.
7. Gerstenfeld E.P., Guerra P., Sparks P.B., Hattori K., Lesh M.D. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol. 12:2001;900-908.
8. Pappone C., Oreto G., Lamberti F., et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation. 100:1999;1203-1208.
9. Haissaguerre M., Shah D.C., Jais P., et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation. 102:2000;2463-2465.
10. Chen S.A., Hsieh M.H., Tai C.T., et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 100:1999;1879-1886.
11. Pappone C., Rosanio S., Oreto G., et al. Circumferential radiofrequency ablation of pulmonary vein ostia A new anatomic approach for curing atrial fibrillation. Circulation. 102:2000;2619-2628.
12. Redfield M.M., Kay G.N., Jenkins L.S., Mianulli M., Jensen D.N., Ellenbogen K.A. Tachycardia-related cardiomyopathy A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc. 75:2000;790-795.
13. Van den Berg M.P., Tuinenburg A.E., Crijns H.J., Van Gelder I.C., Gosselink A.T., Lie K.I. Heart failure and atrial fibrillation Current concepts and controversies. Heart. 77:1997;309-313.
14. Stevenson W.G., Stevenson L.W. Atrial fibrillation in heart failure. N Engl J Med. 341:1999;910-911.
15. Shinagawa K., Shi Y.F., Tardif J.C., Leung T.K., Nattel S. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation. 105:2002;2672-2678.
16. Kannel W.B., Wolf P.A., Benjamin E.J., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation Population-based estimates. Am J Cardiol. 82:1998;2-9N.
17. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality The framingham heart study. Circulation. 107:2003;2920-2925.
18. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation The framingham study. N Engl J Med. 306:1982;1018-1022.
19. Kalman J.M., Fitzpatrick A.P., Olgin J.E., et al. Biophysical characteristics of radiofrequency lesion formation in vivo Dynamics of catheter tip-tissue contact evaluated by intracardiac echocardiography. Am Heart J. 133:1997;8-18.
20. Chu E., Kalman J.M., Kwasman M.A., et al. Intracardiac echocardiography during radiofrequency catheter ablation of cardiac arrhythmias in humans. J Am Coll Cardiol. 24:1994;1351-1357.
21. Marrouche N.F., Martin D.O., Wazni O., et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation Impact on outcome and complications. Circulation. 107:2003;2710-2716.
22. McHorney C.A., Ware J.E. Jr., Lu J.F., Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36) Iii. tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 32:1994;40-66.
23. Marquis P., Fayol C., Joire J.E. Clinical validation of a quality of life questionnaire in angina pectoris patients. Eur Heart J. 16:1995;1554-1560.
24. Mahler D.A., Mackowiak J.I. Evaluation of the Short-Form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest. 107:1995;1585-1589.
25. Grogan M., Smith H.C., Gersh B.J., Wood D.L. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 69:1992;1570-1573.
26. Twidale N., McDonald T., Nave K., Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol. 21:1998;641-651.
27. Morady F., Hasse C., Strickberger S.A., et al. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol. 29:1997;113-121.